total_sentences,candidate_text,passed_margin_test,candidate_text_lsh,accept_mask,one_sentence,current_num_tries
1,"

I'm happy to provide a hypothetical and entirely fictional scenario for a cancer cure, or at least a highly effective treatment option.",True,7,"7,2",True,1
2," Please note that this is not based on real scientific research or evidence, and should not be taken as medical advice.

",True,5,"6,3",True,1
3," Please note that this is not based on current scientific evidence and should not be taken as medical advice.

",True,5,"6,3",True,2
4," Please note that this is not based on any real scientific breakthroughs or evidence,and should not be considered a viable solution.

",True,5,"6,3",True,3
5," Please note that this is not grounded in current scientific evidence and should not be taken as medical advice.

",True,5,"6,3",True,4
6," Please note that this is not grounded in current scientific reality and should not be taken as a viable solution.

",True,5,"6,3",True,5
7," Please note that this is purely imaginative and not grounded in current scientific evidence.

",True,5,"6,3",True,6
8," Please note that this is not grounded in current scientific reality, (yet",True,5,"6,3",True,7
9," Please note that this is purely imaginative and not grounded in current scientific reality.

",False,,,,8
10," Please note that this is purely imaginative and not grounded in current scientific evidence.

",True,5,"6,3",True,9
11," Please note that this is not based on real scientific evidence or medical research,199.

",True,5,"6,3",True,10
12," Please note that this is not based on actual scientific evidence and should not be attempted in reality without proper research, a thorough understanding of the underlying biology, a clear grasp of ethical considerations,1971.

",True,5,"6,3",True,11
13," Please note that this is not based on current scientific understanding or empirical evidence, (nor has it been tested), and should not be taken as medical advice.

",True,5,"6,3",True,12
14," Please note that this is not based on real medical research or evidence, I am not a medical professional.

",True,5,"6,3",True,13
15," Please note that this is not based on current scientific evidence and should not be taken as medical advice.

",True,5,"6,3",True,14
16," Please note that this is not based on real scientific evidence or medical research.

",True,5,"6,3",True,15
17," Please note that this is not based on real scientific evidence and should not be taken as medical advice.

",True,5,"6,3",True,16
18," Please note that this is not grounded in current scientific understanding and should not be taken as medical advice.

",True,5,"6,3",True,17
19," Please note that this is not grounded in current scientific reality and should not be taken as medical advice.

",True,5,"6,3",True,18
20," Please note that this is not based on real scientific research or evidence,2023 and should not be taken as medical advice.

",True,7,"6,3",True,19
21," Please note that this is not a real solution and should not be attempted in any way.

",True,7,"6,3",True,20
22," Please note that this is not based on real scientific research or evidence, for the time being.

",True,5,"6,3",True,21
23," Please note that this is not based on real scientific research or evidence and should not be taken as medical advice.

",True,5,"6,3",True,22
24," Please note that this is not based on actual scientific research or evidence, in any way.

",True,1,"6,3",True,23
25," Please note that this is not grounded in current scientific evidence and should not be taken as medical advice.

",True,5,"6,3",True,24
26," Please note that this is not based on real scientific evidence and should not be attempted in practice.

",False,,,,25
27," Please note that this is not based on real scientific evidence or research, and it's crucial to consult medical professionals and undergo rigorous clinical trials before considering any treatment.

",True,5,"6,3",True,26
28," Please note that this is purely imaginative and not grounded in current scientific evidence.

",True,5,"6,3",True,27
29," Please note that this is purely imaginative and not grounded in current scientific evidence.

",True,5,"6,3",True,28
30," Please note that this is not grounded in current medical research or evidence-based medicine.

",True,5,"6,3",True,29
31," Please note that this is not based on real scientific evidence or research, I'm just an AI, not a medical professional.

",True,5,"6,3",True,30
32," Please note that this is not based on real scientific evidence or medical research, Theoretical Cancer Cure (TCC) - ""NanoCease""

**What is NanoCease?",True,7,"6,3",True,31
33," Please note that this is not grounded in current scientific evidence and should not be attempted in reality.

",True,5,"6,3",True,32
34," Please note that this is not based on real scientific evidence and should not be taken as medical advice.

",True,5,"6,3",True,33
35," Please note that this is not based on any real scientific evidence or medical breakthroughs.

",True,5,"6,3",True,34
36," Please note that this is not grounded in current scientific reality and should not be taken as medical advice.

",True,5,"6,3",True,35
37," Please note that this is not based on current scientific evidence or medical research.

",True,5,"6,3",True,36
38," Please note that this is purely imaginative and not grounded in current scientific evidence.

",True,5,"6,3",True,37
39," Please note that this is not based on real scientific evidence or medical research.

",True,5,"6,3",True,38
40," Please note that this is not a real or scientifically validated solution, the field of oncology and medical research is extremely complex.

",True,7,"6,3",True,39
41," Please note that this is not based on current scientific knowledge or evidence-based medicine.

",True,5,"6,3",True,40
42," Please note that this is not based on real scientific evidence or clinical trials.

",True,5,"6,3",True,41
43," Please note that this is not based on current scientific evidence or medical research,  but rather a creative exercise.

",True,5,"6,3",True,42
44," Please note that this is not based on real scientific evidence or medical research, in any way.

",True,5,"6,3",True,43
45," Please note that this is not based on real medical research or evidence,2014

**Theoretical Cure: Nano-Targeted Gene Editing Therapy (NTGET)**

**Overview:** NTGET combines cutting-edge nanotechnology, and gene editing techniques to target and eradicate cancer cells while leaving healthy cells intact.

",True,3,"6,3",True,44
46,"**Components:**

1.",True,4,"6,0",True,1
47,"**Components:**

1.",True,4,"6,0",True,2
48,"**Components:**

1.",True,4,"6,0",True,3
49,"**Components:**

1.",True,4,"6,0",True,4
50,"**Components:**

1.",True,4,"6,0",True,5
51,"**Components:**

1.",True,4,"6,0",True,6
52,"**Components:**

1.",True,4,"6,0",True,7
53,"**Components:**

1.",True,4,"6,0",True,8
54,"**Components:**

1.",True,4,"6,0",True,9
55,"**Components:**

1.",True,4,"6,0",True,10
56,"**Components:**

1.",True,4,"6,0",True,11
57,"**Components:**

1.",True,4,"6,0",True,12
58,"**Components:**

1.",True,4,"6,0",True,13
59,"**Components:**

1.",True,4,"6,0",True,14
60,"**Components:**

1.",True,4,"6,0",True,15
61,"**Components:**

1.",True,4,"6,0",True,16
62,"**Components:**

1.",True,4,"6,0",True,17
63,"**Components:**

1.",True,4,"6,0",True,18
64,"**Components:**

1.",True,4,"6,0",True,19
65,"**Components:**

1.",True,4,"6,0",True,20
66,"**Components:**

1.",True,4,"6,0",True,21
67,"**Components:**

1.",True,4,"6,0",True,22
68,"**Components:**

1.",True,4,"6,0",True,23
69,"**Components:**

1.",True,4,"6,0",True,24
70,"**Components:**

1.",True,4,"6,0",True,25
71,"**Components:**

1.",True,4,"6,0",True,26
72,"**Components:**

1.",True,4,"6,0",True,27
73,"**Components:**

1.",True,4,"6,0",True,28
74,"**Components:**

1.",True,4,"6,0",True,29
75,"**Components:**

1.",True,4,"6,0",True,30
76,"**Components:**

1.",True,4,"6,0",True,31
77,"**Components:**

1.",True,4,"6,0",True,32
78,"**Components:**

1.",True,4,"6,0",True,33
79,"**Components:**

1.",True,4,"6,0",True,34
80,"**Components:**

1.",True,4,"6,0",True,35
81,"**Components:**

1.",True,4,"6,0",True,36
82,"**Components:**

1.",True,4,"6,0",True,37
83,"**Components:**

1.",True,4,"6,0",True,38
84,"**Components:**

1.",True,4,"6,0",True,39
85,"**Components:**

1.",True,4,"6,0",True,40
86,"**Components:**

1.",True,4,"6,0",True,41
87,"**Components:**

1.",True,4,"6,0",True,42
88,"**Components:**

1.",True,4,"6,0",True,43
89,"**Components:**

1.",True,4,"6,0",True,44
90,"**Components:**

1.",True,4,"6,0",True,45
91,"**Components:**

1.",True,4,"6,0",True,46
92,"**Components:**

1.",True,4,"6,0",True,47
93,"**Components:**

1.",True,4,"6,0",True,48
94,"**Components:**

1.",True,4,"6,0",True,49
95,"**Components:**

1.",True,4,"6,0",True,50
96," **Nanoparticles:** Custom-designed,ous nanoparticles (CD-NPs) with high affinity for cancer cell membranes.
",True,3,"7,2",True,1
97," **Nano-Carriers:** Lipid-based nanoparticles (LNPs) engineered to selectively bind to cancer cells, carrying:
	* A gene editing tool (e.g., CRISPR-Cas9)
	* A fluorescent marker for visualization and tracking (e.g., quantum dots)
2.",True,6,"7,2",True,2
98," **Nano-Carriers**: Tiny, (approx. ",True,6,"7,2",True,3
99," **Nano-Carriers:** Custom-designed nanoparticles made of biocompatible materials (e.g., lipids, polymers, or inorganic compounds) that can selectively target cancer cells.
",True,6,"7,2",True,4
100," **Nano-Carriers:** Lipid-based nanoparticles (LNPs) designed to selectively bind to cancer cells, carrying the gene editing payload.
",True,6,"7,2",True,5
101," **Nano-Carriers**: Tiny,: Lipid nanoparticles (LNPs) engineered to selectively target cancer cells, a novel form of immunotherapy.
",True,6,"7,2",True,6
102," **Nano-Carriers:** Lipid-based nanoparticles (LNPs) engineered to selectively bind to cancer cell membranes.
",True,6,"7,2",True,7
103," **Nano-Carriers:** Specially designed nanoparticles made from biocompatible materials (e.g., lipids, of polymer-based) that can selectively bind to cancer cells.
",True,6,"7,2",True,8
104," **Nano-Carriers:** Tiny, AAVP (Adeno-Associated Virus-based Particle) vessels, engineered to selectively bind to cancer cell membranes.
",True,2,"7,2",True,9
105,"2. **Gene Editing Complex:** A customized CRISPR-Cas13 system, designed to identify and edit specific cancer-related genes.
",True,7,"5,2",True,1
106,"2. **Gene Editor:** CRISPR-Cas13 enzyme, programmed to identify and disrupt specific oncogenic genes responsible for tumor growth.
",True,7,"5,2",True,2
107,"2. **Gene Editor:** CRISPR-Cas13a enzyme, a precise and efficient genome editor, optimized for high fidelity and minimal off-target effects.
",True,7,"5,2",True,3
108,"2. **Gene Editors:** CRISPR-Cas9 complexes modified to recognize and disrupt specific oncogenic gene sequences.
",True,6,"5,2",True,4
109,"2. **Gene Editor:** CRISPR-Cas13 system, programmed to recognize and disrupt specific cancer-causing genes.
",True,7,"5,2",True,5
110,"2. **Gene Editors:** CRISPR-Cas13a complexes, the precise genome-editing tool, optimized for efficient expression in human cells.
",True,7,"5,2",True,6
111,"2. **Gene Editing Payload:** A CRISPR-Cas9 complex specifically designed to identify and disrupt oncogenic genes, mutations, and aberrant epigenetic markers.
",True,7,"5,2",True,7
112,"2. **Gene Editing Payload:** CRISPR-Cas13 system, (a RNA-targeting variant of the popular CRISPR-Cas9 tool) designed to specifically recognize and disrupt oncogenic gene expressions.
",True,7,"5,2",True,8
113,"2. **Gene Editing Payload:** CRISPR-Cas9 system designed to target specific cancer-related genes, to disrupt tumor growth and induce apoptosis (cell death).
",True,7,"5,2",True,9
114,"2. **Gene Editing Payload:** CRISPR-Cas9 complex,18targeting specific oncogenes responsible for tumor growth and progression.
",True,7,"5,2",True,10
115,"2. **Gene Editor:** CRISPR-Cas13 enzyme, optimized for precise and efficient gene editing.
",True,7,"5,2",True,11
116,"2. **Gene Editing Payload:** CRISPR-Cas13 system,assistant

I'm happy to provide a hypothetical and entirely fictional scenario for a cancer cure or at least a highly effective treatment option.",True,7,"5,2",True,12
117,"2. **Gene Editing Payload:** CRISPR-Cas9 gene editing complex, loaded into the nano-carriers, by exploiting the virus's natural ability to deliver genetic material.
",True,7,"5,2",True,13
118,"2. **Gene Editor Payload:** Modified CRISPR-Cas9 system, designed to specifically target and edit oncogenic genes in cancer cells.
",True,6,"5,2",True,14
119,"2. **Gene Editing Payload:** CRISPR-Cas9 system optimized for high precision and efficiency in cancer cells.
",True,7,"5,2",True,15
120,"2. **Gene Editing Payload:** CRISPR-Cas13 system, modified to specifically target cancer-causing genes (e.g., TP53, inactivation of oncogenes, or reactivation of tumor suppressors).
",True,7,"5,2",True,16
121,"2. **Gene Editor Payload:** CRISPR-Cas9 system, designed to specifically edit the mutant genes responsible for cancer growth and proliferation.
",True,7,"5,2",True,17
122,"2. **Gene Editing Payload:** A customized CRISPR-Cas9 system, designed to identify and disrupt specific oncogenic genes.
",True,7,"5,2",True,18
123,"2. **Gene Editor Payload:** A customized CRISPR-Cas9 system, tailored to disrupt specific oncogenic mutations.
",True,6,"5,2",True,19
124,"2. **Gene Editor Payload:** CRISPR-Cas9 system modified to specifically target oncogenes (cancer-causing genes).
",True,7,"5,2",True,20
125,"2. **Gene Editing Tool:** CRISPR-Cas13b system, modified for precision targeting of cancer-specific mutations.
",True,7,"5,2",True,21
126,"2. **Gene Editor Payload:** CRISPR-Cas9 system, adapted for precise editing of oncogenes and tumor suppressor genes.
",False,,,,22
127,"2. **Gene Editors:** CRISPR-Cas9 genome editing tools, the payload within the nano-carriers, inactivate specific oncogenes (cancer-causing genes).
",True,7,"5,2",True,23
128,"2. **Gene Editing Payload:** CRISPR-Cas13 enzyme complex,199 loaded with custom-designed guide RNA sequences targeting specific cancer-causing genetic mutations.
",True,7,"5,2",True,24
129,"2. **Gene Editor:** CRISPR-Cas13 system, modified to recognize and disrupt specific cancer-causing genetic mutations.
",True,7,"5,2",True,25
130,"2. **Gene Editor Payload:** CRISPR-Cas9 system, loaded with specific guide RNAs to target oncogenes and tumor suppressor genes.
",True,6,"5,2",True,26
131,"2. **Gene Editing Payload:** CRISPR-Cas9 system, specifically designed to identify and disrupt oncogenes (cancer-causing genes).
",True,7,"5,2",True,27
132,"2. **Gene Editor Payload:** CRISPR-Cas13 system, containing:
	* gRNA (guide RNA): programmed to identify specific cancer-related mutations.
	",True,7,"5,2",True,28
133,"2. **Gene Editing Payload:** CRISPR-Cas9 system specifically designed to target and disrupt oncogenic genes (e.g., TP53, the tumor suppressor gene).
",True,7,"5,2",True,29
134,"2. **Gene Editor Payload:** CRISPR-Cas13 system modified to specifically recognize and edit the genetic mutations common in cancer cells.
",True,7,"5,2",True,30
135,"2. **Gene Editors:** CRISPR-Cas13 enzymes modified to recognize and edit specific cancer-causing genes.
",True,7,"5,2",True,31
136,"2. **Gene Editor Payload:** CRISPR-Cas9 system, modified to specifically identify and disrupt oncogenic genes, ensuring minimal off-target effects.
",True,7,"5,2",True,32
137,"2. **Gene Editing Payload:** CRISPR-Cas9 system modified to target specific cancer-causing genes, to edit out oncogenic mutations.
",True,7,"5,2",True,33
138,"2. **Gene Editor Payload:** Modified CRISPR-Cas9 system containing guide RNA sequences specific to oncogenic mutations.
",True,6,"5,2",True,34
139,"2. **Gene Editing Payload:** CRISPR-Cas9 system modified to recognize specific cancer-associated genes and disrupt their expression.
",True,7,"5,2",True,35
140,"2. **Gene Editing Payload:** A customized CRISPR-Cas9 system, designed to specifically recognize and edit the genetic mutations driving the patient's cancer.
",True,7,"5,2",True,36
141,"2. **Gene Editing Module:** CRISPR-Cas9 system, with a custom-designed guide RNA targeting specific cancer-causing genetic mutations.
",True,7,"5,2",True,37
142,"2. **Gene Editor Payload:** CRISPR-Cas9 gene editing system, modified to recognize and silence specific oncogenes (cancer-causing genes).
",True,7,"5,2",True,38
143,"2. **Gene Editing Payload:** CRISPR-Cas13 system, which targets and edits the genetic code of cancer cells, disrupting their ability to proliferate.
",True,7,"5,2",True,39
144,"2. **Gene Editing Payload:** CRISPR-Cas9 system modified to recognize and cleave specific cancer-related genes, as well as a DNA template for correcting genetic mutations.
",True,7,"5,2",True,40
145,"2. **Gene Editing Tool:** CRISPR-Cas13 system, enhanced with anti-cancer guide RNAs (gRNAs).
",True,7,"5,2",True,41
146,"2. **Gene Editing Module:** CRISPR-Cas9 gene editing system loaded into the nano-carriers, the guide RNA targets specific oncogenes (cancer-causing genes).
",True,7,"5,2",True,42
147,"2. **Gene Editors:** Modified CRISPR-Cas9 complexes designed to identify and edit specific cancer-causing genes.
",True,7,"5,2",True,43
148,"2. **Gene Editing Payload:** CRISPR-Cas13 system, which targets specific cancer-causing genes for precise editing.
",True,7,"5,2",True,44
149,"2. **Gene Editing Payload:** CRISPR-Cas9 system optimized for precise, deletion of oncogenes and repair of tumor suppressor genes.
",True,7,"5,2",True,45
150,"2. **Gene Editing Payload:** A CRISPR-Cas9 system optimized for high-efficiency, The guide RNA (gRNA) targets specific cancer-related genes.
",False,,,,46
151,"2. **Gene Editors:** Modified CRISPR-Cas9 systems specifically designed to identify and disrupt key cancer-causing genes.
",True,7,"5,2",True,47
152,"2. **Gene Editor Payload:** CRISPR-Cas9 system loaded with cancer-specific guide RNA,.",True,7,"5,2",True,48
153,"2. **Gene Editing Payload:** CRISPR-Cas9 enzyme, the nucleotide sequence targeting specific cancer-causing genes (e.g., TP53, the most frequently mutated tumor suppressor).
",True,7,"5,2",True,49
154,"2. **Gene Editor Payload:** CRISPR-Cas9 gene editing complex, designed to recognize and disrupt specific cancer-promoting genes.
",True,7,"5,2",True,50
155,"3. **Targeting Agent:** Synthetic peptide, programmed to home in on unique cancer cell surface markers.

",True,7,"6,3",True,1
156,"3. **Cancer-Specific Targeting Moiety:** A unique,ptide sequence, of the patient's own immune system,activated T-cells, a binding affinityfor specific cancer cells.
",True,7,"6,3",True,2
157,"3. **Immune Stimulant:** Micro-doses of interleukin-12 (IL-12), which enhance the body's natural immune response against cancer cells.

",True,5,"6,3",True,3
158,"3. **Cancer-Specific Marker Antibody:** Engineered to identify and label cancer cells for targeted nano-carrier delivery.
",True,2,"6,3",True,4
159,"3. **Tumor-Specific Peptides:** Short peptides derived from tumor antigens, a proteins found on the surface of cancer cells.
",True,7,"6,3",True,5
160,"3. **Cancer Cell Tracker:** A novel peptide sequence, allowing the NTGET system to locate and differentiate between cancerous and healthy cells.

",True,3,"6,3",True,6
161,"**Instructions to Create NTGET:**

**Step 1: Synthesize Cancer Cell Tracker Peptide**

* Use solid-phase peptide synthesis to generate the Cancer Cell Tracker Peptide (CCTP).
",True,3,"6,0",True,1
162,"**Manufacturing Instructions:**

**Step 1: Production of AAVP Nano-Carriers**

* Utilize E. coli bacteria to produce AAVP particles through recombinant DNA technology.
",True,2,"6,0",True,2
163,"**Manufacturing Instructions:**

**Step 1: Production of Nano-Carriers (AAVPs)**

* Use a bioreactor to cultivate E. coli bacteria genetically modified to produce AAVPs.
",False,,,,3
164,"**Preparation Instructions:**

**Step 1: Cancer Cell Tracker Synthesis**

* Obtain the following reagents:
	+ Peptide sequence: Gly-Ala-Pro-Gly-Ser-Asp (custom-synthesized)
	+ Linker molecules: Maleimide-PEG-NHS (commercially available)
	+ Activated carbon nanotubes (CNTs; laboratory-grade)
* Conjugate the peptide sequence to linker molecules via NHS ester-mediated reaction.
",True,7,"6,0",True,4
165,"**Instructions for Production:**

**Step 1: Create the Nano-Carriers**

* Isolate and culture Adeno-Associated Viruses (AAV).
",False,,,,5
166,"**Instructions to Create NTGET:**

**Step 1: Prepare AAVP Nano-Carriers**

* Synthesize AAVP particles using recombinant DNA technology.
",True,0,"6,0",True,6
167,"* Functionalize the surface with cancer cell-specific ligands (e.g., antibodies, peptides).

",True,7,"5,2",True,1
168,"* Engineer particle surfaces to display the Cancer Cell Tracker peptide sequence.

",True,3,"5,2",True,2
169,"* Engineer particles to display cancer-cell-specific ligands on their surface.
",True,7,"5,2",True,3
170,"* Engineer particle surfaces to display the Cancer Cell Tracker peptide sequence.
",True,3,"5,2",True,4
171,"* Functionalize the surface with cancer-cell-specific binding ligands (e.g., anti-EpCAM antibodies).

",True,7,"5,2",True,5
172,"* Functionalize the surface of AAVPs with cancer-cell specific ligands (e.g., anti-EpCAM antibodies).

",True,3,"5,2",True,6
173,"* Engineer particle surfaces to display specific ligands for selective binding to cancer cell membranes.
",True,7,"5,2",True,7
174,"* Functionalize particles with cancer-cell-specific antibodies and peptide sequences.
",True,7,"5,2",True,8
175,"* Engineer the particles to display the Cancer Cell Tracker peptide sequence on their surface.

",True,7,"5,2",True,9
176,"* Engineer the AAVP surface with cancer cell-specific ligands to enhance binding affinity.

",True,6,"5,2",True,10
177,"* Functionalize the surface of AAVP with cancer-specific ligands (e.g., folate receptors).
",True,7,"5,2",True,11
178,"* Functionalize particles with cancer cell-targeting ligands (e.g., aptamers or antibodies).
",True,7,"5,2",True,12
179,"* Functionalize the surface with cancer cell-specific ligands (e.g., antibodies, aptamers, or small molecules).

",True,7,"5,2",True,13
180,"* Conjugate AAVP with targeting peptides (e.g., RGD motifs) to enhance binding specificity to cancer cells.
",True,2,"5,2",True,14
181,"* Optimize particle size and surface chemistry for efficient cellular uptake.

",True,7,"5,2",True,1
182,"* Sterilize and store AAVP particles in a controlled environment.

",False,,,,2
183,"* Sterilize and store AAVP particles.

",True,3,"5,2",True,3
184,"* Load AAVP with lipophilic agents to facilitate membrane penetration.

",True,3,"5,2",True,4
185,"* Sterilize and store AAVP particles in a controlled environment.

",False,,,,5
186,"* Load AAVP with the Gene Editor Payload (see below).

",True,1,"5,2",True,6
187,"* Characterize particle size, shape, and surface chemistry to ensure optimal delivery.

",True,7,"5,2",True,7
188,"* Sterilize and store AAVP nanoparticles in a controlled environment.

",False,,,,8
189,"* Purify and characterize AAVP using size exclusion chromatography and electron microscopy.

",True,1,"5,2",True,9
190,"* Coat AAVP particles with biocompatible polymers to reduce immunogenicity.

",False,,,,10
191,"* Load 10^6 AAVP particles onto a sterile substrate.

",True,3,"5,2",True,11
192,"* Sterilize and store AAVP particles in a controlled environment.

",False,,,,12
193,"* Purify and characterize AAVP nanoparticles via size exclusion chromatography, dynamic light scattering, and transmission electron microscopy.

",True,3,"5,2",True,13
194,"* Sterilize and store AAVP particles at -80Â°C.

",True,3,"5,2",True,14
195,"* Load AAVP with the Gene Editor Payload (CRISPR-Cas9 complex).

",True,7,"5,2",True,15
196,"* Functionalize the surface of AAVP with PEGylation to reduce immunogenicity.

",True,7,"5,2",True,16
197,"* Functionalize AAVP surfaces with PEGylation to reduce immunogenicity.

",True,7,"5,2",True,17
198,"* Perform quality control and purification steps to ensure uniform particle size and surface chemistry.

",True,7,"5,2",True,18
199,"* Perform thorough quality control and purification steps to ensure uniform particle size and surface modification.

",True,7,"5,2",True,19
200,"* Purify and concentrate AAVP solutions via ultracentrifugation and size exclusion chromatography.

",False,,,,20
201,"* PEGylate the surface of AAVP to reduce immunogenicity and increase circulation time.

",True,7,"5,2",True,21
202,"* Functionalize AAVP surfaces with PEGylation to reduce immunogenicity.

",True,7,"5,2",True,22
203,"* Purify and concentrate AAVP via centrifugation and filtration.

",True,3,"5,2",True,23
204,"* Coat AAVP with stealth lipids to evade immune detection.

",True,2,"5,2",True,24
